Molecular Haplotyping of Long Genomic Distances of DNA

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$100,000.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43HG003422-01
Award Id:
70857
Agency Tracking Number:
HG003422
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
GLC BIOTECHNOLOGY, INC., 33175 ROCKFORD DR, SOLON, OH, 44139
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
BAOCHUAN GUO
(440) 349-2193
B.GUO@CSUOHIO.EDU
Business Contact:
BAOCHUAN GUO
(440) 349-2191
B.GUO@CSUOHIO.EDU
Research Institute:
n/a
Abstract
This SBIR project is proposed to commercialize a novel method referred as PDESA for revealing patient's individual haplotypes. Our preliminary data shown that PDESA could reveal haplotypes of sequences of 134kb in length, which is about three times longer than the longest sequence haplotyped using other molecular methods. PDESA is simple, easy to implement, and importantly, it works! Thus, this project is warranted. Phase I of this SBIR project is to further demonstrate the feasibility of PDESA and the specific aims of Phase I are: Aim 1: applying PEDSA to hapiotyping a sequence block near the IBD5 locus to establish the fact that PDESA is indeed, a robust, general molecular method for haplotyping; Aim 2: evaluating the accuracy of PDESA by haplotyping a family with a total of 16 individuals in both the ApoE4 and IBD5 loci; and Aim 3: demonstrating the feasibility of using PDESA to haplotype ultra long distances of genomic DNA (longer than 150kb). The goals in Phase II will be (1) to develop the assays that meet the requirements of clinical applications; (2) to develop rapid, easy kits for haplotyping a number of genes of functional and clinical significance, including both individual and multiplexed assays; (3) to develop assays for haplotyping of potential clinical and commercial value, identified in the scientific literature and/or HAPmap database for genes presumed to have values. By the end of this project, we shall have many well-developed assays that are ready to implement for haplotyping both short and long distances of DNA in an accurate, robust, low-cost, high-throughput manner. Thus, success of this project will not only be of commercial significance to GLC Biotechnology Inc., but also will have profound impacts on many fields, particularly on pharmacogenetics, and personalized medicine.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government